FSMDX
Price
$42.45
Change
-$0.00 (-0.00%)
Updated
Jul 10 closing price
Net Assets
53.23B
HFDFX
Price
$22.48
Change
+$0.01 (+0.04%)
Updated
Jul 10 closing price
Net Assets
1.09B
Interact to see
Advertisement

FSMDX vs HFDFX

FSMDX vs HFDFX Comparison Chart in %
View a ticker or compare two or three
VS
FSMDX vs. HFDFX commentary
Jul 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Hold and HFDFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 53.2B vs. HFDFX (1.09B). FSMDX pays higher dividends than HFDFX: FSMDX (0.76) vs HFDFX (0.41). FSMDX was incepted earlier than HFDFX: FSMDX (15 years) vs HFDFX (9 years). HFDFX (0.80) is less costly to investors than FSMDX (0.03). HFDFX is a more actively managed with annual turnover of: 62.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than HFDFX: FSMDX (0) vs HFDFX (1000000). FSMDX annual gain was more profitable for investors over the last year : 18.68 vs. HFDFX (15.76). FSMDX return over 5 years is better than : 43.30 vs. HFDFX (10.91).
FSMDXHFDFXFSMDX / HFDFX
Total Expense Ratio0.030.803%
Annual Report Gross Expense Ratio0.030.803%
Fund Existence15 years9 years-
Gain YTD14.94718.19182%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets53.2B1.09B4,872%
Annual Yield % from dividends0.760.41184%
Returns for 1 year18.6815.76119%
Returns for 3 years53.1428.14189%
Returns for 5 years43.3010.91397%
Returns for 10 years166.09N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAKGX40.390.28
+0.70%
Oakmark Global Investor
MLVOX18.690.06
+0.32%
MFS Low Volatility Equity R2
TQVIX22.130.05
+0.23%
T. Rowe Price Integrated US LCV Eq I
CGVFX30.85N/A
N/A
American Funds Global Insight 529-F-1
BMSBX17.07-0.03
-0.18%
MFS Blended Research Mid Cap Eq B